HMM101 Medical Biotechnology - Clinical Trials and Regulation

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/30

flashcard set

Earn XP

Description and Tags

Flashcards on Clinical trials, animal welfare, ethics and drug regulation.

Last updated 1:42 AM on 5/15/25
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai

No analytics yet

Send a link to your students to track their progress

31 Terms

1
New cards

Acknowledgment of Country

Acknowledge the Wurundjeri and Wadawurrung people of the Kulin nations as the Traditional Owners of the land.

2
New cards

Universal Declaration on Animal Welfare (UDAW)

A proposed inter-governmental agreement to recognize that animals are sentient, to prevent cruelty and reduce suffering.

3
New cards

The Three Rs

Reduction, Refinement, and Replacement of animals in research.

4
New cards

The Five Freedoms

Freedom from thirst and hunger, discomfort, pain/injury/disease, ability to express normal behavior, and fear/distress.

5
New cards

Pathways to ‘Cure’ disease

Drug discovery & proof of concept -> Pre-clinical in vitro & animal studies -> Clinical trials Phases I-III -> Govt Review -> Large scale manufacture Phase IV -> Approval

6
New cards

Clinical Trial (WHO Definition)

Research study that prospectively assigns human participants to health-related interventions to evaluate the effects on health outcomes.

7
New cards

Purpose of Clinical Trials

Prevent, detect, treat, or manage various diseases or medical conditions.

8
New cards

Clinical Trial Interventions

Experimental drugs, cells, biological products, vaccines, medical devices, diagnostics, treatments, therapies, health service changes, preventive care, and educational interventions.

9
New cards

Phase I Clinical Trial

Small number of participants (e.g., 20-80) to evaluate safety and determine safe dosage range/side effects.

10
New cards

Phase II Clinical Trial

Larger group of people (hundreds) to determine efficacy and further evaluate safety.

11
New cards

Phase III Clinical Trial

Large groups of participants (hundreds to thousands) to study efficacy, compare to other interventions, monitor adverse effects, and collect safety information.

12
New cards

Phase IV Clinical Trial

Done after an intervention has been marketed to monitor effectiveness in the general population and collect information about adverse effects over longer periods.

13
New cards

Clinical Trial Protocol

A plan that describes what researchers will do in the study; ensures safety and accurate measurements.

14
New cards

Types of Trial Protocols: Comparing a new intervention to a standard intervention

Compares a new intervention with a standard or commonly used intervention.

15
New cards

Types of Trial Protocols: Comparing a new intervention with a placebo

Compares a new intervention with a dummy treatment (sugar pill) that has no known health effect.

16
New cards

The Placebo Effect

When you believe you are taking effective medicine, so your symptoms improve.

17
New cards

Randomisation

Participants are allocated to each group without decision by anyone involved in running the trial (usually done by a computer).

18
New cards

Blinding/Masking

Participants and/or researchers don’t know who is receiving the new intervention.

19
New cards

Single Blind Trial

Participants do not know which intervention they are receiving, but the researchers and medical staff do.

20
New cards

Double Blind Trial

Neither the researchers organizing the trial nor those taking part in the trial know who is receiving which intervention.

21
New cards

BEST Clinical Trials

Double Blind, Randomised, Placebo controlled

22
New cards

Orphan drugs

Rare conditions that affect a few people -Usually fast tracked when it comes to approval

23
New cards

Clinical Trial Team

Doctors, nurses, health care professionals, biostatisticians, trial coordinators and monitors.

24
New cards

Trial Guidelines

Guidelines about who can take part in a clinical trial (inclusion and exclusion criteria).

25
New cards

Indigenous health research

Focuses more on a collaborative partnership of researchers and local communities- getting consent from local leaders of the community

26
New cards

Epistemology

Is the study of knowledge acquisition. It involves an awareness of certain aspects of reality, and it seeks to discover what is known and how it is known

27
New cards

Why Regulate Drugs?

Effective drug regulation is required to ensure the safety, efficacy and quality of drugs, as well as the accuracy and appropriateness of the drug information available to the public.

28
New cards

USFDA (Food and Drug Administration)

An agency of the United States Department of Health and Human Services, responsible for protecting and promoting public health through the regulation and supervision of various products.

29
New cards

TGA (Therapeutic Goods Administration)

Part of the Australian Government Department of Health and Ageing, responsible for regulating therapeutic goods including medicines, medical devices, blood and blood products.

30
New cards

Is it a medicine or food?

A product's principal use is of primary consideration when determining whether it is a food or a medicine.

31
New cards

Is it a therapeutic good or a cosmetic?

The claims made about the product.